Even though only a few studies have assessed ERBB2 differential expression between population groups, the results gathered so far suggest that there are differences in gene expression by genetic ancestry that may account for differences in the biology, prognosis, and outcomes of breast cancer between population groups (52). The gene discussed is ERBB2; the disease is breast carcinoma.